tiprankstipranks
Advertisement
Advertisement

OCGN Stock Latest News

Ocugen granted RMAT designation for OCU410
The FlyOcugen granted RMAT designation for OCU410
3d ago
OCGN
OCGN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OCGN Upcoming Earnings Report: What to Expect?
3d ago
OCGN
Ocugen inks OCU400 licensing deal for MENA
PremiumCompany Announcements
Ocugen inks OCU400 licensing deal for MENA
19d ago
8K
OCGN
Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical
PremiumThe Fly
Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical
19d ago
OCGN
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1M ago
CGC
CPB
Nasdaq, Take-Two, Fastly, Ocugen, Sony Insider Shock
PremiumWeekend UpdatesNasdaq, Take-Two, Fastly, Ocugen, Sony Insider Shock
1M ago
FSLY
NDAQ
Ocugen Stockholders Approve Proposals and Confirm Leadership
Premium
Company Announcements
Ocugen Stockholders Approve Proposals and Confirm Leadership
2M ago
8K
OCGN
Ocugen Consolidates Financial Leadership Under New Accounting Officer
Premium
Company Announcements
Ocugen Consolidates Financial Leadership Under New Accounting Officer
2M ago
8K
OCGN
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
NFE
YSS
Ocugen price target lowered to $11 from $12 at Canaccord
PremiumThe Fly
Ocugen price target lowered to $11 from $12 at Canaccord
2M ago
OCGN
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News
5 Healthcare Stocks Set to Join the Russell 3000
2M ago
QSI
AGEN
Ocugen Raises $130 Million Through Convertible Notes Offering
PremiumCompany Announcements
Ocugen Raises $130 Million Through Convertible Notes Offering
3M ago
8K
OCGN
Ocugen Announces Interim Chief Medical Officer Appointment Transition
PremiumCompany AnnouncementsOcugen Announces Interim Chief Medical Officer Appointment Transition
3M ago
8K
OCGN
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
Premium
Ratings
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
3M ago
OCGN
Ocugen Raises Capital Through Convertible Senior Notes Offering
Premium
Company Announcements
Ocugen Raises Capital Through Convertible Senior Notes Offering
3M ago
8K
OCGN
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
PremiumCompany Announcements
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
3M ago
8K
OCGN
Ocugen reports Q1 EPS (6c), consensus (5c)
PremiumThe Fly
Ocugen reports Q1 EPS (6c), consensus (5c)
3M ago
OCGN
Ocugen Announces Private Convertible Notes Offering to Deleverage
PremiumCompany Announcements
Ocugen Announces Private Convertible Notes Offering to Deleverage
3M ago
8K
OCGN
Ocugen announces private offering of $115M of convertible senior notes
PremiumThe Fly
Ocugen announces private offering of $115M of convertible senior notes
3M ago
OCGN
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
PremiumRatingsOcugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
3M ago
OCGN
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
OCGN
Ocugen completes dosing in GARDian3 trial
Premium
The Fly
Ocugen completes dosing in GARDian3 trial
4M ago
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >